       Document 2670
 DOCN  M94A2670
 TI    HIV surveillance and blood donor screening in Zimbabwe.
 DT    9412
 AU    Chitsva J; National Blood Transfusion Service Bulawayo Branch, Zimbabwe.
 SO    Int Conf AIDS. 1994 Aug 7-12;10(1):251 (abstract no. PB0434). Unique
       Identifier : AIDSLINE ICA10/94369905
 AB    OBJECTIVE: To monitor the effectiveness of blood donor screening
       procedures and HIV testing in the National Blood Transfusion Service of
       Zimbabwe. (NBTS) METHODS: New procedures for blood donor screening were
       implemented and HIV figures were monitored from all the 5 NBTS centres.
       Different categories of blood donor populations were analysed. Western
       blots were done on all indeterminate ELISA results on repeat donations.
       RESULTS: Presently, the all inclusive HIV percentage in total blood
       donations is less than 2% from an upward trend which was exceeding 5% by
       1989. Adults had higher prevalence figures than Secondary school boys
       and girls, and girls had higher figures than boys at Secondary schools.
       Some regular donors are sero converting. Western blot results have
       cleared many donors. DISCUSSION AND CONCLUSIONS: The current 2% may look
       like an achievement compared to the estimated seroprevalence in the
       general population but there is need to improve on this yet still obtain
       sufficient blood to satisfy the demand. The Secondary school donors
       contribute more than 60% of the total blood collected but the risk of
       HIV infection increases as they become sexually active.
 DE    Adolescence  Adult  *AIDS Serodiagnosis  *Blood Donors  *Blood
       Transfusion  Blotting, Western  *Developing Countries  Enzyme-Linked
       Immunosorbent Assay  Female  Human  HIV
       Seropositivity/DIAGNOSIS/IMMUNOLOGY/*TRANSMISSION  HIV Seroprevalence
       Male  *Mass Screening  *Population Surveillance  Predictive Value of
       Tests  Risk Factors  Zimbabwe  MEETING ABSTRACT

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

